Capecitabine Added To Standard Treatment Given Before Surgery Helps To Eradicate Tumours In Patients With Early Breast Cancer

Posted by Jeff Daas on Sep 24th, 2009 | one comment

Data from the ABCSG-24 study presented at the joint 15th ECCO and 34th ESMO congress in Berlin, Germany, show that adding capecitabine (Xeloda(R)) to anthracycline- and taxane-containing regimens prior to surgery (neoadjuvant therapy) completely eradicated the tumour in 24% of women with HER2-positive or HER2-negative early breast cancer.
Read Full Article

One Response to “Capecitabine Added To Standard Treatment Given Before Surgery Helps To Eradicate Tumours In Patients With Early Breast Cancer”

1. Business Tax Guru says:

   November 23, 2009 at 1:22 am

   I’ve been included in taxes for lengthier then I care to admit, both on the personal side (all my working life-time!!) and from a legal standpoint since satisfying the bar and following up on tax law. I’ve offered a lot of advice and redressed a lot of wrongs, and I must say that what you’ve posted makes complete sense. Please continue the good work – the more individuals know the better they’ll be armed to deal with the tax man, and that’s what it’s all about.